Article

A polo-like kinase inhibitor identified by computational repositioning attenuates pulmonary fibrosis

2022-12-07

Abstract excerpt

<h4>Background: </h4> Idiopathic pulmonary fibrosis (IPF) is a fatal fibrotic lung disease with few effective therapeutic options. Recently, drug repositioning, which involves identifying novel therapeutic potentials for existing drugs, has been popularized as a new approach for the development of novel therapeutic reagents. However, this approach has not yet been fully utilized in the field of pulmonary fibrosis....

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 3f3e2e25-5981-58b4-b804-d9a8566b3c93
DOI: 10.21203/rs.3.rs-2320212/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A polo-like kinase inhibitor identified by computational repositioning attenuates pulmonary fibrosisDOI 10.21203/rs.3.rs-2320212/v1Read

Identification of Targetable Kinases in Idiopathic Pulmonary FibrosisSemantic proximity Read

PDE4B inhibition by nerandomilast: Effects on lung fibrosis and transcriptome in fibrotic rats and on biomarkers in human lung epithelial cellsSemantic proximity Read

Identification of targetable kinases in idiopathic pulmonary fibrosisSemantic proximity Read

Identification and molecular modelling of potential drugs targeting the genes involved in the progression of lung cancer in patients with idiopathic pulmonary fibrosisSemantic proximity Read

Genetic Deletion of Polo-Like Kinase 2 Induces a Pro-Fibrotic Pulmonary Phenotype.Semantic proximity Read

Polypharmacology is an enduring and nearly universal property of kinase inhibitorsSemantic proximity Read

The Cyclin-Dependent Kinase 8 Inhibitor E966-0530-45418 Attenuates Pulmonary Fibrosis In Vitro and In VivoSemantic proximity Read

Pan-transcriptome-based Candidate Therapeutic Discovery for Idiopathic Pulmonary FibrosisSemantic proximity Read

AI-assisted Drug Re-purposing for Human Liver FibrosisSemantic proximity Read

Integrative Analysis of the Therapeutic Mechanisms of Astragaloside IV in Idiopathic Pulmonary Fibrosis via Network Pharmacology and Molecular ValidationSemantic proximity Read

Tankyrase inhibition demonstrates anti-fibrotic effects in preclinical pulmonary fibrosis modelsSemantic proximity Read

The mechanism of triptolide in the treatment of connective tissue disease-related interstitial lung disease using network pharmacology and molecular dockingSemantic proximity Read